Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 260 clinical trials
  • None views
  • None views
  • None views
  • None views
  • None views
UPENN Case Test Trial 1 In Different Account (Sanofi) (Do Not Make Any Changes)  

UPENN Case Test Trial 1 In Different Account (Sanofi) (Do Not Make Any Changes)

  • 0 views
  • 21 Aug, 2025
  • 1 location
FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma

Patients with resectable adenocarcinoma of the stomach or the esophagogastric junction (II-III type by Siewert) without previous therapy will be treated with one of two chemotherapy combinations before and after surgery.

adenocarcinoma
gastric tumor
irinotecan
cytostatic
adenocarcinoma of the gastroesophageal junction
  • 0 views
  • 05 Aug, 2020
FOLFOX6 Versus mFOLFIRINOX as First Line Chemotherapy in Metastatic Gastric Cancer or Esophagogastric Junction Adenocarcinoma (Type II-III)

Patients with metastatic adenocarcinoma of the stomach or the esophagogastric junction (II-III type by Siewert) without previous therapy will be treated with one of two chemotherapy combinations .

adenocarcinoma
irinotecan
metastatic adenocarcinoma
adenocarcinoma of the gastroesophageal junction
oxaliplatin
  • 0 views
  • 16 Feb, 2024
  • 1 location
RCT on Effect of Lymph Node Mapping by Indocyanine Green Via Submucosal or Subserosal Injection

The purpose of this study was to evaluate whether submucosal or subserous injection of indocyanine green during laparoscopic lymph node dissection of gastric cancer was different in tracing lymph nodes of gastric cancer. The patients with gastric adenocarcinoma (cT1-4a, Nmuramel +, M0) were studied.

gastric adenocarcinoma
gastric cancer
adenocarcinoma
papillary adenocarcinoma
mucinous adenocarcinoma
  • 0 views
  • 16 Feb, 2024
  • 1 location
Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body

This phase III trial studies how well the addition of radiotherapy to the usual treatment (chemotherapy) works compared to the usual treatment alone in treating patients with esophageal and gastric cancer that has spread to a limited number of other places in the body (oligometastatic disease). Radiotherapy uses high energy …

esophageal adenocarcinoma
ct scan
positron emission tomography
pathologic stage iv gastric cancer ajcc v8
oxaliplatin
  • 0 views
  • 16 Feb, 2024
  • 255 locations